Relationships between maternal novel adipocytokines and bone biomarkers in complicated by gestational hypertensive disorders and normal pregnancies

References

• Namgung R, Tsang RC. Bone in the pregnant mother and newborn at birth. Clin Chim Acta 2003;333:1–11
   PubMed Web of Science ®Google Scholar
• Ulrich U, Miller PB, Eyre DR, et al. Bone remodeling and bone mineral density during pregnancy. Arch Gynecol Obstet 2003;268:309–16
   PubMedGoogle Scholar
• Moller UK, Vio Streym S, Mosekilde L, Rejnmark L. Changes in bone mineral density and body composition during pregnancy and postpartum. A controlled cohort study. Osteoporos Int 2012;23:1213–23
   PubMed Web of Science ®Google Scholar
• Shaarawy M, Zaki S, Ramzi AM, et al. Feto-maternal bone remodeling in normal pregnancy and preeclampsia. J Soc Gynecol Investig 2005;12:343–8
   PubMedGoogle Scholar
• Dorota DK, Bogdan KG, Mieczyslaw G, et al. The concentrations of markers of bone turnover in normal pregnancy and preeclampsia. Hypertens Pregnancy 2012;31:166–76
   PubMed Web of Science ®Google Scholar
• Morikawa H, Chough SY, Ohara N, et al. Pregnancy induced hypertension (PIH) and osteoporosis. Nippon Naibunpi Zasshi 1989;65:1123–34
   PubMedGoogle Scholar
• Lalau JD, Jans I, el Esper N, et al. Calcium metabolism, plasma parathyroid hormone, and calcitriol in transient hypertension of pregnancy. Am J Hypertens 1993;6:522–7
   PubMed Web of Science ®Google Scholar
• Magni P, Dozio E, Galliera E, et al. Molecular aspects of adipokine-bone interactions. Curr Mol Med 2010;10:522–32
   PubMedGoogle Scholar
• Biver E, Salliot C, Combescure C, et al. Influence of adipokines and ghrelin on bone mineral density and fracture risk: a systematic review and meta-analysis. J Clin Endocrinol Metab 2011;96:2703–13
   PubMed Web of Science ®Google Scholar
• Briana DD, Malamitsi-Puchner A. Adipocytokines in normal and complicated pregnancies. Reprod Sci 2009;16:921–37
   PubMed Web of Science ®Google Scholar
• Briana DD, Boutsikou M, Baka S, et al. Perinatal changes of plasma resistin concentrations in pregnancies with normal and restricted fetal growth. Neonatology 2008;93:153–7
   PubMed Web of Science ®Google Scholar
• Malamitsi-Puchner A, Gourgiotis D, Boutsikou M, et al. Circulating apelin concentrations in mother/infant pairs at term. Acta Paediatr 2007;96:1751–4
   PubMed Web of Science ®Google Scholar
• Malamitsi-Puchner A, Briana DD, Boutsikou M, et al. Perinatal circulating visfatin levels in intrauterine growth restriction. Pediatrics 2007;119:e1314–18
   PubMed Web of Science ®Google Scholar
• Briana DD, Gourgiotis D, Boutsikou M, et al. Perinatal bone turnover in term pregnancies: the influence of intrauterine growth restriction. Bone 2008;42:307–13
   PubMed Web of Science ®Google Scholar
• Briana DD, Boutsikou M, Baka S, et al. Circulating osteoprotegerin and sRANKL concentrations in the perinatal period at term: the impact of intrauterine growth restriction. Neonatology 2009;96:132–6
   PubMedGoogle Scholar
• Gardosi J, Chang A, Kalyan B, et al. Customised antenatal growth charts. Lancet 1992;339:283–7
   PubMed Web of Science ®Google Scholar
• Brown MA, Lindheimer MD, de Swiet M, et al. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 2001;20:IX–XIV
   PubMed Web of Science ®Google Scholar
• Anim-Nyame N, Sooranna SR, Jones J, et al. A longitudinal study of biochemical markers of bone turnover during normal pregnancy and pregnancies complicated by pre-eclampsia. BJOG 2002;109:708–13
   PubMed Web of Science ®Google Scholar
• Thomas T, Burguera B. Is leptin the link between fat and bone mass? J Bone Miner Res 2002;17:1563–9
   PubMed Web of Science ®Google Scholar
• Holloway WR, Collier FM, Aitken CJ, et al. Leptin inhibits osteoclast generation. J Bone Miner Res 2002;17:200–9
   PubMed Web of Science ®Google Scholar
• Huang KC, Cheng WC, Yen RF, et al. Lack of independent relationship between plasma adiponectin, leptin levels and bone density in nondiabetic female adolescents. Clin Endocrinol (Oxf) 2004;61:204–8
   PubMed Web of Science ®Google Scholar
• Fisher A, Southcott E, Li R, et al. Serum resistin in older patients with hip fracture: relationship with comorbidity and biochemical determinants of bone metabolism. Cytokine 2011;56:157–66
   PubMed Web of Science ®Google Scholar
• Thommesen L, Stunes AK, Monjo M, et al. Expression and regulation of resistin in osteoblasts and osteoclasts indicate a role in bone metabolism. J Cell Biochem 2006;99:824–34
   PubMed Web of Science ®Google Scholar
• Oh KW, Lee WY, Rhee EJ, et al. The relationship between serum resistin, leptin, adiponectin, ghrelin levels and bone mineral density in middle-aged men. Clin Endocrinol (Oxf) 2005;63:131–8
   PubMed Web of Science ®Google Scholar
• Xie H, Tang SY, Luo XH, et al. Insulin-like effects of visfatin on human osteoblasts. Calcif Tissue Int 2007;80:201–10
   PubMed Web of Science ®Google Scholar
• Iacobellis G, Iorio M, Napoli N, et al. Relation of adiponectin, visfatin and bone mineral density in patients with metabolic syndrome. J Endocrinol Invest 2011;34:e12–15
   PubMed Web of Science ®Google Scholar
• Xie H, Yuan LQ, Luo XH, et al. Apelin suppresses apoptosis of human osteoblasts. Apoptosis 2007;12:247–54
   PubMedGoogle Scholar
• Hu PF, Chen WP, Tang JL, et al. Apelin plays a catabolic role on articular cartilage: in vivo and in vitro studies. Int J Mol Med 2010;26:357–63
   PubMedGoogle Scholar
• Peng XD, Xie H, Zhao Q, et al. Relationships between serum adiponectin, leptin, resistin, visfatin levels and bone mineral density, and bone biochemical markers in Chinese men. Clin Chim Acta 2008;387:31–5
   PubMed Web of Science ®Google Scholar
• Zhang H, Xie H, Zhao Q, et al. Relationships between serum adiponectin, apelin, leptin, resistin, visfatin levels and bone mineral density, and bone biochemical markers in post-menopausal Chinese women. J Endocrinol Invest 2010;33:707–11
   PubMed Web of Science ®Google Scholar